Clin2
NCT07288294Possibly a fitRecruiting

Primary care strategies for weight management after stopping medication

Obesity

Part of Hormones & metabolism clinical trials.

This study looks at different ways to help you keep weight off after you stop taking a weight loss medication. You will work with your primary care team to learn healthy habits and get support without the drug.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
214 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are at least 18 years old.
  • You are currently prescribed and taking a weight loss medication (like liraglutide, semaglutide, or tirzepatide) from your primary care doctor at Rush University System for Health.
  • You are willing to temporarily stop taking that medication as part of the study.
  • You do not have diabetes (type 1 or type 2).
  • You are not currently pregnant or planning to get pregnant.
  • You have not had weight loss surgery in the last 2 years, and your weight is under 375 pounds.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07729332Not yet recruiting· Phase 4
Switching to oral weight-loss pills to prevent regain after stopping GLP-1 injections

This study is for people who have lost weight using GLP-1 injections (like semaglutide or tirzepatide) and are thinking about stopping them. It tests whether switching to an oral weight-loss medication can help you keep the weight off.

Boston, Massachusetts
NCT07770841Recruiting· Phase 3
Oral medication for weight loss study

This study tests an oral medicine (semaglutide) to see if it helps adults with excess weight lose weight. It might offer an easier, pill-based treatment option for weight management.

Birmingham, Alabama
NCT07319975Not yet recruiting
Weight-loss drugs plus exercise for obesity

This study tests whether two weight-loss medications, semaglutide and tirzepatide, combined with an exercise program can help people with obesity lose weight. It may help you if you are looking for a structured medical approach to weight loss.

Istanbul, Zeytinburnu
NCT07213466Recruiting· Phase 4
Personalized weight-loss medication for bipolar disorder

This study wants to see if a personalized approach with FDA-approved weight-loss medications can help people with bipolar disorder who are overweight or have obesity, while staying on their mood stabilizer treatment. It might be a good fit if you have bipolar disorder and struggle with your weight.

Rochester, Minnesota
NCT06885736Recruiting
Preserving muscle with exercise and protein on weight loss drugs

This trial tests whether adding resistance exercise and extra protein can help you keep your muscle while taking weight loss medications like semaglutide or tirzepatide. It is for people with a BMI of 27 or higher who are not already exercising regularly.

Kuwait City
NCT07091500Recruiting
Exercise and a weight-loss drug for people with obesity

This trial tests whether combining a GLP-1 medication (a type of diabetes drug that also helps with weight loss) with an exercise program can improve physical function in people with obesity. If you are obese and have trouble with daily activities, this study may help you become more mobile and healthier.

St Louis, Missouri

Hear when a new Obesity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.